Ventic, Ivy C.
HRN: 28-01-68 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/30/2025
CEFUROXIME 1.5GM (VIAL)
10/30/2025
11/06/2025
IV
1.5gm
Q8
Cholelithiasis
Checking Final Appropriateness
11/16/2025
CEFUROXIME 1.5GM (VIAL)
11/16/2025
11/23/2025
IV
1.5g
Q8
Cholelithiases
Waiting Final Action